Special Considerations For Pneumovax Recalls

Pneumovax requires special consideration.

Recalling patients for Pneumovax immunisation presents a challenge because Pneumovax is indicated for both age (18 months and 50 years) and a range of chronic diseases. The latter presents a challenge in keeping Automated Recall Types up-to-date as additional disease Clinical Item Types are defined in Communicare.

Recommendation

Ensure all users are properly trained in the use of Communicare and understand the importance of reading displayed warnings. Administer Pneumovax at the time of diagnosis of an indicating chronic condition, or at least adjust the existing recall.

Generally don't generate recalls on both OnRegistration and OnPresentation events, though it can be done successfully if due care and diligence are exercised. For more information, see Recalling on both OnRegistration and OnPresentation Events.